Filter News
Area of Research
- (-) Fusion Energy (1)
- (-) Neutron Science (6)
- Advanced Manufacturing (2)
- Biology and Environment (4)
- Clean Energy (16)
- Computer Science (1)
- Fusion and Fission (2)
- Isotopes (2)
- Materials (12)
- Materials for Computing (1)
- Nuclear Science and Technology (8)
- Quantum information Science (1)
- Supercomputing (14)
News Topics
- (-) Advanced Reactors (1)
- (-) Bioenergy (2)
- (-) Biomedical (3)
- (-) Nuclear Energy (1)
- (-) Quantum Science (2)
- 3-D Printing/Advanced Manufacturing (1)
- Climate Change (1)
- Computer Science (4)
- Coronavirus (3)
- Environment (2)
- Fusion (2)
- Materials Science (6)
- Microscopy (1)
- Nanotechnology (4)
- National Security (1)
- Neutron Science (20)
- Physics (3)
- Summit (4)
- Sustainable Energy (1)
- Transportation (1)
Media Contacts
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
Five researchers at the Department of Energy’s Oak Ridge National Laboratory have been named ORNL Corporate Fellows in recognition of significant career accomplishments and continued leadership in their scientific fields.
Scientists at ORNL used neutron scattering and supercomputing to better understand how an organic solvent and water work together to break down plant biomass, creating a pathway to significantly improve the production of renewable
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
A team led by the Department of Energy’s Oak Ridge National Laboratory synthesized a tiny structure with high surface area and discovered how its unique architecture drives ions across interfaces to transport energy or information.
The U.S. Department of Energy announced funding for 12 projects with private industry to enable collaboration with DOE national laboratories on overcoming challenges in fusion energy development.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.